References
- Pui CH, Carroll WL, Meshinche S, Arceci RJ. Biology risk stratification, and therapy of pediatric acute leukemia: an update. J Clin Oncol 2011;29:551–565.
- Swerdlow SH, Harris NL, Jaffe ES, et al. , editors. World Health Organization classification of tumours. Pathology and genetics: tumours of hematopoietic tissues. LyonIARC Press2008.
- Schlenk RF, Benner A, Krauter J, et al. Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. J Clin Oncol 2004;22:3741–3750.
- Harrison CJ, Hills RK, Moorman AV, et al. Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials MAL 10 and 12. J Clin Oncol 2010;28:2674–2681.
- Kim H, Moon HW, Hur M, et al. Acute myeloid leukemia with a RUNX1-RUNX1T1 t(1;21;8)(q21;q22;q22) novel variant: a case report and review of the literature. Acta Hematol 2011;125: 237–241.
- Huang L, Abruzzo LV, Valbuena JR, et al. Acute myeloid leucemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies. Am J Clin Pathol 2006;125:267–272.
- Bae SY, Kim JS, Ryeu BJ, et al. Acute myeloid leukemia (AML-M2) associated with variant t(8;21): report of three cases. Cancer Genet Cytogenet 2010;199:31–37.
- Available from: http://www.cancer.gov/clinicaltrials/UCHM-AML-BFM-2004.
- Shaffer LG Slovak ML, Campbell LJ, editors. ISCN 2009: An International System for Human Cytogenetic NomenclatureBaselKarger2009.
- Liehr T, Heller A, Starke H, et al. Microdissection based high resolution multicolor banding for all 24 human chromosomes. Int J Mol Med 2002;9:335–339.
- Rowley JD. Identification of a translocation with quinacrine fluorescence in a patient with acute leukemia. Ann Genet 1973;16:109–112.
- Radtke I, Mullighan CG, Ishii M, et al. Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proc Natl Acad Sci USA 2009;106:12944–12949.
- Byrd JC, Dodge RK, Carroll A, et al. Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol 1999;17:3767–3775.
- Cairoli R, Beghini A, Grillo G, et al. Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study. Blood 2006;107:3463–3468.
- Silva MLM, Raimondi SC, Abdelhay E, et al. Banding and molecular cytogenetics studies detected a CBFB-MYH11 fusion gene that appeared as abnormal chromosomes 1 and 16 in a baby with acute myeloid leukemia M4Eo. Cancer Genet Cytogenet 2008;182:56–60.
- Figueiredo AF, Liehr T, Bahtt S, et al. A new cryptic ins(11;1)(q23;q21q31) detected in a t(1;8;11)(q21;p21;q23) in a baby with acute myeloid leukemia FAB AMLM5. Blood Cells Mol Disease 2010;45:197–198.
- Udayakumar AM, Alkindi S, Pathare AV, et al. Complex t(8;13;21)(q22;q14;q22)–a novel variant of t(8;21) in a patient with acute myeloid leukemia (AML-M2). Arch Med Res 2008;39:252–256.